Remove Cannabinoids Remove DEA Remove Extraction Remove Programs
article thumbnail

Empire State Cannabis Update: CCB Makes Progress In Hemp Program & Chair Hints At Adult-Use Timeline

Cannabis Law Report

Cannabinoid Hemp Program Regulations (Finally) Finalized. While much attention is focused on New York’s adult-use cannabis market, the CCB and Office of Cannabis Management (OCM) are also responsible for overseeing both the Medical Marijuana and Cannabinoid Hemp Programs. cannabinoid hemp and hemp extract.”

article thumbnail

Hemp-CBD: Deadline Approaching to Submit Comments on USDA Interim Hemp Rule

Canna Law Blog

That is the DEA’s interim final rule suggesting that in-process hemp extract shall be treated as a schedule I controlled substance during any point at which its THC concentration exceeds 0.3 The DEA Just Passed a BAD Interim Rule Impacting Hemp CBD and Other Cannabinoids. percent on a dry weight basis.

Hemp 90
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What Happened to Hemp?

Canna Law Blog

Before the 2018 Farm Bill, only a few states ran limited “research” pilot programs for hemp. Many of those cannabinoid products are now made from legacy U.S. Bad policy and the new cannabinoids markets It always starts with policy. He said: “licensed acres in hemp are at pre-farm bill levels.” Could that be true?

Hemp 85
article thumbnail

United States: Hemp And CBD Regulation: Beyond Delta-8 THC

Cannabis Law Report

… and all derivatives, extracts, cannabinoids, isomers, acids, salts, and salts of isomers … with a delta-9 tetrahydrocannabinol [THC] concentration of not more than 0.3 Enforcement falls, for the most part, to states like New York, who have moved on their own to regulate hemp derived cannabinoids. 1, 2022).

THC 105
article thumbnail

Clever Leaves and Biopharmaceutical Research Company to Partner for Landmark Cannabis Research Study in Collaboration with the University of California, Davis

Cannabis Law Report

NASDAQ: CLVR, CLVRW) (“Clever Leaves” or the “Company”), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, and Biopharmaceutical Research Company (“BRC”), a specialty pharmaceutical company that holds federal licenses for importing, analyzing and manufacturing controlled substances in the U.S.,

article thumbnail

CBD: Everything You Need to Know

CannaMD

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system.

CBD 99
article thumbnail

Hemp and CBD: Submit Your Comments on USDA Interim Hemp Rules By December 30

Canna Law Blog

The hemp industry is up in arms over the USDA’s interim rules establishing a domestic hemp program. Most of us in the hemp industry are well-aware of the major issues in the interim rules: 15-day pre-harvest testing requirements, total THC, DEA laboratories, and crop insurance to name a few. 3% Total THC.

Hemp 72